Related Experiment Video

Updated: Jan 20, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.2K

Raising serum urate levels in Parkinson disease: A strategy only for women?

Angel Chamorro1, Pablo Mir2

  • 1From the Comprehensive Stroke Center, Department of Neuroscience (A.C.), Hospital Clinic of Barcelona; School of Medicine (A.C.), University of Barcelona; August Pi I Sunyer Biomedical Research Institute (IDIBAPS) (A.C.), Barcelona; Unidad de Trastornos del Movimiento (P.M.), Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla; and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (P.M.), Seville, Spain. achamorro@clinic.cat.

Neurology
|September 6, 2019
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease03:20

Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease

Published on: September 22, 2023

2.3K
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

32.3K

Related Concept Videos

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model06:07

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model

This study presents a method to analyze the morphology of mitochondria based on immunostaining and image analysis in mouse brain tissue in situ. It also describes how this allows one to detect changes in mitochondrial morphology induced by protein aggregation in Parkinson's disease...
2.2K
Measuring Constipation in a Drosophila Model of Parkinson's Disease03:20

Measuring Constipation in a Drosophila Model of Parkinson's Disease

This protocol presents an assay for modeling constipation in an alpha-synuclein based Drosophila model of Parkinson's disease.
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1000
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test08:06

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Parkinson disease is caused by loss of dopaminergic innervation to the striatum, which can be experimentally induced by 6-OH-dopamine. We describe how to perform a stereotaxic lesion and to monitor apomorphine-induced rotational behavior in mice. This model is useful and reliable for testing new therapies for Parkinson...
32.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Ole Isacson: Development of New Therapies for Parkinson's Disease23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson gives a concise overview of Parkinsons's disease, its causes, therapeutic strategies, and advances in Parkinson's...
8.4K